Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryostatin 1 in Platinum-Resistant Ovarian Cancer
NCT00004008Phase 2Completed
- Sponsor
- University of Glasgow
- Start
- Jul 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bryostatin-1 in ovarian epithelial cancer, sponsored by University of Glasgow. Started Jul 1999; status: completed.
02
Drugs
bryostatin-1
03
Conditions
ovarian epithelial cancer
Beyond the preview
Go deeper on NCT00004008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004008.